Serpil Yanık Colak

Dr. Serpil Yanık Colak

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2025 in Medicina
Verified
Journal Article
Open access
PDF file
SCSerpil Yanık Colak
Serpil Yanık Colak
BABurak Andac
Burak Andac
EÖEray Özgün
Eray Özgün
BBBuket Yilmaz Bulbul
Buket Yilmaz Bulbul
MOMine Okur
Mine Okur
Mehmet CelikMehmet Celik
Mehmet Celik
Background and Objectives: MG53 is a myokine/cardiokine involved in membrane repair. Some preclinical studies suggest that it is associated with insulin resistance. Metabolic syndrome (MS) is manifested by dyslipidemia, hypertension (HT), visceral obesity, hyperinsulinism, and glucose intolerance. We aimed to evaluate the relationship between the MG53 protein and MS and its components. Materials and Methods: This study was conducted among 64 patients with MS and 64 age- and sex-matched healthy participants. MG53 levels were measured using Human-MG53, a commercially available enzyme-linked immunosorbent assay (ELISA) kit (Cat# CSB-EL024511HU, Alfagen laboratory supplies, Cusabio, Bornova, İzmir.). Results: There was no significant connection between serum MG53 levels and the presence of MS (p = 0.969). We found no correlation between serum MG53 levels and the presence of HT, weight, waist circumference, body mass index, HDL-C, fasting blood glucose, and HbA1c levels. Conclusions: This study’s results suggest no association between serum MG53 levels and MS parameters in the studied ethnic population. Due to the limited number and controversy of available studies on this subject, our findings may provide perspective for conducting studies with more diverse populations to obtain more comprehensive results.

1 January 2024 in Eurasian Journal of Medical Advances
Verified
Journal Article
Closed access
SCSerpil Yanık Colak
Serpil Yanık Colak
YAYüksel Altuntaş
Yüksel Altuntaş
Objectives: In this study, we aimed to investigate the effects of factors related to lifestyle, treatment compliance, and eating habits on blood glucose regulation in patients diagnosed with Type 2 DM (Diabetes Mellitus) with HbA1c 10% and above who are receiving intensive insulin therapy. Methods: The study sample consisted of 100 diabetic patients with inadequate glycemic control who applied to our clinic between January 2015 and December 2016. A questionnaire developed by the researchers was used in the study. The patients' sociodemographic and anthropometric characteristics, eating habits, compliance with insulin treatment, physical activity, and dental health data were documented. Results: Of the patients included in our study, 75% were female and 25% were male, the average age was 60, the average HbA1c was 12.3%, and the average Body Mass Index was 31.7 kg/m2. While 88% of our patients stated that they had three main meals a day, 12% stated that they skipped at least one main meal, and 64% had irregular eating habits. Forty percent of our patients skipped insulin doses at least 1-2 times a week, and there was a statistically significant relationship between the frequency of insulin dose skipping and HbA1c subgroups (p=0.014). Sixty-seven percent of our patients did not exercise daily. Conclusion: Although education level, eating habits, exercise, and dental health are among the variables affecting glycemic control in diabetic patients, the most critical factor affecting glycemic control in our study group was a lack of compliance with insulin injection.

31 October 2023 in Akdeniz Medical Journal
Verified
Journal Article
Open access
PDF file
BABurak Andac
Burak Andac
BBBuket Yılmaz Bülbül
Buket Yılmaz Bülbül
MTMehmet Oğulcan Tezel
Mehmet Oğulcan Tezel
MOMine Okur
Mine Okur
SCSerpil Yanık Colak
Serpil Yanık Colak
Mehmet CelikMehmet Celik
Mehmet Celik
Objective: To assess the vitamin D levels between adults with type 1 diabetes mellitus and the healthy control group and evaluate the relationship between HbA1c levels and vitamin D status in the diabetic group. Methods: Our cross-sectional, descriptive study included 98 type 1 diabetic patients over 18 years old who applied to the Endocrinology Outpatient Clinic and 95 age- and sex-matched individuals without chronic disease. Patients with advanced renal or liver disorders, primary hyperparathyroidism, metabolic bone disorders, or using medications that might change vitamin D concentrations were excluded from the study. HbA1c and 25(OH) Vitamin-D3 levels were measured three times in 9 months, and the average of the measurements was used. Diabetic patients and control individuals were separated into three groups according to their vitamin D levels as follows: deficiency ( 20 ng/ml). Results: Serum 25 (OH) vitamin D levels of diabetic patients were significantly lower than in healthy individuals (p=0.024). However, when diabetic adults were separated into three groups according to 25(OH) vitamin D levels, there was no significant difference regarding HbA1c levels (p=0.905). Conclusion: Although preclinical data support the role of low serum vitamin D levels in the etiopathogenesis of type 1 diabetes mellitus, studies examining the connection between low serum vitamin D levels and the prevalence of type 1 diabetes or glycemic control are not sufficient to reach a clear conclusion, including our study.

8 December 2023 in Namık Kemal Tıp Dergisi
Verified
Journal Article
Closed access
SCSerpil Yanık Colak
Serpil Yanık Colak
EÖEray Özgün
Eray Özgün
BABurak Andac
Burak Andac
MOMine Okur
Mine Okur
BBBuket Yilmaz Bülbül
Buket Yilmaz Bülbül
Mehmet CelikMehmet Celik
Mehmet Celik